This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Kips Bay Medical (NASDAQ:KIPS), an innovative cardiac surgery company, today announced it would report its financial results for the second quarter of 2011 on Wednesday, August 10, 2011 after market close. The announcement will be followed by a conference call with the investment community the following day, Thursday August 11, 2011 beginning at 8:00 am CT / 9:00 am ET.
Kips Bay Medical Chairman and Chief Executive Officer, Manny Villafaña, and Chief Financial Officer, Scott Kellen, will provide the current US and International regulatory and reimbursement status for the eSVS MESH.
To listen to the call live, please dial
800-901-5218 (domestic) or
+1-617-786-4511 (international). The access participant code is
19594896. To access a simultaneous webcast of the conference call via the internet, go to the “Investors” section of the Company’s website located at
A replay of the conference call by telephone will be available starting at 11:00 am CT/12:00 noon ET August 11, 2011 and continuing until August 18, 2011. To hear this replay, dial
888-286-8010 (domestic) or
+1-617-801-6888 (international) and enter the passcode
62778378. A replay of the conference call will also be available via the internet starting August 11, 2011 and continuing for at least 12 months. To access a replay of the conference call via the internet, go to the “
Investors – Audio Archives” section of the Company’s website located at
About Kips Bay Medical
Kips Bay Medical, Inc., founded in 2007 and headquartered in Minneapolis, Minnesota, is a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, or eSVS MESH, for use in coronary artery bypass grafting surgery. Our eSVS MESH is a nitinol mesh sleeve that, when placed over a saphenous vein graft during CABG surgery, is designed to improve the structural characteristics and long-term performance of the saphenous vein graft. Additional information about Kips Bay Medical, Inc. can be found at